Bayer
100 Bayer Boulevard
Whippany
New Jersey
07981
United States
Tel: 1-877-229-3727
Website: http://www.career.bayer.us/
Email: careersus@bayer.com
About Bayer
It all starts with a friendship between two men, plenty of natural curiosity and two kitchen stoves. Businessman Friedrich Bayer and dyer Johann Friedrich Weskott use these to conduct experiments and eventually discover how to make the dye fuchsine.
On August 1, 1863, they found the "Friedr. Bayer et. comp." company in Wuppertal-Barmen, a 19th century startup with tremendous potential.
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
Our goal is to create value for our customers, stockholders and employees, while also strengthening the company’s earning power. We are committed to operating sustainably and addressing our social and ethical responsibilities. Employees with a passion for innovation enjoy excellent development opportunities at Bayer.
All this goes to make up our purpose: Science for a better life.
Passion to innovate | Power to change
584 articles with Bayer
-
Bayer UK unveils new Artificial Intelligence (AI) ‘LifeHub’ to optimise data-driven drug discovery and disease detection & diagnosis
10/10/2019
Bayer Plc launches LifeHub UK as part of a global network of Bayer global innovation hubs. LifeHub UK is designed to accelerate and optimise disease detection and data-driven drug discovery by developing Artificial Intelligence (AI)-enabled imaging solutions.
-
Sensyne Health Partners with Bayer on New UK Artificial Intelligence ‘LifeHub’ for Data-Driven Drug Discovery, Disease Detection and Diagnosis
10/10/2019
Expands on existing collaboration agreement with Bayer to accelerate the development of new treatments for cardiovascular disease using clinical AI
-
Bayer Announces Support for the 12th Annual 4-H National Youth Science Day
10/10/2019
Bayer is proud to announce its support of National 4-H Council's National Youth Science Day (4-H NYSD) by supplying engaging STEM education kits for students in rural areas whose schools have limited internet access and resources.
-
Eurecon Verlag Gmbh: 20th Pharma Trend Image & Innovation Awards – These Are the 2019 Winners
10/10/2019
Bayer Vital with its subsidiary Jenapharm is the “Best Pharmaceutical Company” in the 2019 Pharma Trend Ranking. Novartis Pharma and Roche Pharma take second and third place, respectively, followed by Janssen-Cilag and Bristol-Myers Squibb.
-
Lawsuit Settlement News Announces Assistance for Plaintiffs in Roundup Weed Killer Lawsuits
10/10/2019
Premier mass tort servicing firm available to help plaintiffs find a lawyer or seek lawsuit funding from their Bayer Monsanto case
-
Climate FieldView™ Teams Up with Tillable™ to Improve Farm Data Transparency
10/10/2019
Leading Digital Farming Platform Forges Partnership with Land-leasing Pioneer
-
GlobalData recently published their top 20 global pharma companies categorized by market capitalization in the first quarter of 2019.
-
Ionis' Factor XI anti-thrombotic medicine advances with Bayer following positive clinical results
10/9/2019
Ionis Pharmaceuticals, Inc. announced that the company has been notified by its partner Bayer about the decision to advance IONIS-FXI-LRx following positive clinical results.
-
Bayer announces second annual Grants Fur Families program, giving $70,000 to domestic violence shelters supporting survivors and their pets
10/8/2019
Bayer announces another round of aid for domestic violence shelters, via the Grants Fur Families program
-
Bayer Supports Federal Employment Protection for LGBT+ Employees
10/8/2019
The Supreme Court of the United States will be reviewing three cases (Altitude Express, Inc. v. Zarda; Bostock v. Clayton County; and R.G. & G.R. Harris Funeral Homes, Inc. v. EEOC) that take up the question of whether employment discrimination based on sexual orientation or gender identity is prohibited by Title VII of the Civil Rights Act of 1964.
-
BioSpace scanned the WARN (Worker Adjustment and Retraining Notification) notices across the country and compiled a small list of recent layoffs across the industry.
-
In 2017, a lawsuit was filed alleging that Eli Lilly and Bayer, as well as other companies, attempted to use the free nursing services as a way to boost sales of diabetes drugs, such as Humalog and Humulin, as well as other drugs.
-
Bayer Announces Updated Analysis for Vitrakvi® (larotrectinib) Demonstrating High Response Rate and Duration of Response of Nearly Three Years in Adults and Children with TRK Fusion Cancer
9/28/2019
New data cut-off confirmed Vitrakvi is the only TRK inhibitor to demonstrate an overall response rate (ORR) of nearly 80 percent in an expanded population of more than 150 patients, including an ORR of 75 percent in patients with brain metastases
-
Aspirin Continues to be the Gold Standard Treatment for Millions of Americans Who Have Had a Cardiovascular Event
9/26/2019
TWILIGHT Study Fails to Answer Key Scientific Question Regarding Most Efficacious Treatment Post-PCI
-
BioSpace Global Roundup, Sept. 26
9/26/2019
Companies from across the globe share updates on their business and pipelines. -
According to the second biennial 2019 Life Sciences Ideal Employer Report by BioSpace, the top three most important attributes cited by life sciences professionals around the world are the opportunity to do interesting and meaningful work, a competitive salary and health benefits.
-
BioSpace, the leader in life sciences news and careers, today announced that Genentech, Pfizer, Merck, Amgen and Novartis landed in the top five spots of their latest Ideal Employer report.
-
Aleve® Demonstrates More Pain Relief Than Acetaminophen for Menstrual Cramps, Study Shows
9/25/2019
Bayer today announced data demonstrating that a single maximum non-prescription dose of Aleve® (naproxen sodium) provided more pain relief over 12 hours than acetaminophen for menstrual cramps due to primary dysmenorrhea
-
Bayer, Brigham and Women's Hospital, Massachusetts General Hospital open joint lab for research of new treatments for chronic lung diseases
9/24/2019
Investment of over USD 30 million spanning five years to research and develop new treatments for chronic lung diseases
-
Bayer, Brigham and Women's Hospital and Massachusetts General Hospital have launched a joint laboratory to research new drugs to treat chronic lung diseases.